Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa
Clinical trials sponsored by Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa, explained in plain language.
A biopharmaceutical company developing respiratory therapies, now a subsidiary of Merck.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New inhaler aims to cut dangerous lung Flare-Ups in bronchiectasis patients
Disease control Recruiting nowThis study tests an inhaled drug called ensifentrine in 284 adults with non-cystic fibrosis bronchiectasis, a lung condition that causes frequent infections and breathing problems. Participants will receive either the drug or a placebo twice daily for at least 24 weeks. The goal …
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New inhaler drug shows promise for COPD inflammation
Disease control Recruiting nowThis study tests whether a nebulized drug called ensifentrine can reduce inflammation in the lungs of people with COPD. About 56 adults aged 40-80 who smoke or have smoked will receive both the drug and a placebo at different times over 24 weeks. The main goal is to see changes i…
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC